← Evidence map

ArticleTherapeutic advances in medical oncology2024

A non-inferiority, phase III trial of gemcitabine plus capecitabine

Xiaodong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39634173